Mafia History - Season 1 Backdrop Blur
Mafia History - Season 1 Poster
NR 1 Seasons • 4 Episodes

Mafia History - Season 1

A documentary film series on the Italian Mafia Cosa Nostra, exploring its codes, exploring its activities, witnessing its trials, including the 1986 Maxi Trial, and unveiling new aspects such as the eminent role played by women, recently discovered by Italian magistrates.

Top Cast

Overview

A documentary film series on the Italian Mafia Cosa Nostra, exploring its codes, exploring its activities, witnessing its trials, including the 1986 Maxi Trial, and unveiling new aspects such as the eminent role played by women, recently discovered by Italian magistrates.

Recommendations

Biography

Biography is a documentary television series. It was originally a half-hour filmed series produced for CBS by David Wolper from 1961 to 1964 and hosted by Mike Wallace. The A&E Network later re-ran it and has produced new episodes since 1987. The older version featured historical figures such as Helen Keller and Mark Twain, or long-dead entertainment figures such as Will Rogers or John Barrymore. The A&E series has placed the emphasis on such people as Marilyn Monroe, Elvis Presley, Plácido Domingo, Freddie Mercury, Jacqueline Kennedy Onassis, Eric Clapton, Pope John Paul II, Gene Tierney, Selena, Diego Rivera, Mao Zedong and Queen Elizabeth II, and fictional characters like The Phantom, Superman, Hamlet, Betty Boop, and Santa Claus. The program ended up profiling enough figures that in 1999, A&E spun it off into an entire network, The Biography Channel.

Biography

6.7 1987
Drugs, Inc.

Drugs: A multi-billion-dollar industry that fuels crime and violence like no other substance on the planet. Turning cartel leaders into billionaires, the illegal drug industry also provides vital income to hundreds of thousands of poor workers across the globe. While some users sacrifice their lives to an addiction they can't escape, others find drugs to be their only saving grace from physical or emotional pain almost impossible to overcome. Where should the lines be drawn in this lucrative industry?

Drugs, Inc.

8.3 2010